166 related articles for article (PubMed ID: 38069119)
1. The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes.
Danek PJ; Daniel WA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069119
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Chronic Treatment with Lurasidone on Rat Liver Cytochrome P450 Expression and Activity in the Chronic Mild Stress Model of Depression.
Kot M; Haduch A; Papp M; Daniel WA
Drug Metab Dispos; 2017 Dec; 45(12):1336-1344. PubMed ID: 28935656
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms.
Danek PJ; Kuban W; Daniel WA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445153
[TBL] [Abstract][Full Text] [Related]
4. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes.
Serron SC; Dwivedi N; Backes WL
Toxicol Appl Pharmacol; 2000 May; 164(3):305-11. PubMed ID: 10799341
[TBL] [Abstract][Full Text] [Related]
5. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
6. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment.
Kim H; Putt DA; Zangar RC; Wolf CR; Guengerich FP; Edwards RJ; Hollenberg PF; Novak RF
Drug Metab Dispos; 2001 Mar; 29(3):353-60. PubMed ID: 11181506
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Gukang Capsules on activity and protein expression of hepatic cytochrome P450 enzymes in rats].
Yang C; Li J; Sun J; Lu DY; Chen SS; Li YJ; Wang YL; Liu T
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5936-5943. PubMed ID: 36472013
[TBL] [Abstract][Full Text] [Related]
9. Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices.
Meredith C; Scott MP; Renwick AB; Price RJ; Lake BG
Xenobiotica; 2003 May; 33(5):511-27. PubMed ID: 12746107
[TBL] [Abstract][Full Text] [Related]
10. Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy.
Danek PJ; Wójcikowski J; Daniel WA
Toxicol Appl Pharmacol; 2020 Nov; 406():115239. PubMed ID: 32941854
[TBL] [Abstract][Full Text] [Related]
11. Effects of metyrapone on expression of CYPs 2C11, 3A2, and other 3A genes in rat hepatocytes cultured on matrigel.
Goodwin B; Liddle C; Murray M; Tapner M; Rooney T; Farrell GC
Biochem Pharmacol; 1996 Jul; 52(2):219-27. PubMed ID: 8694846
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.
Danek PJ; Bromek E; Daniel WA
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209648
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
14. Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver.
Fabrizi L; Gemma S; Testai E; Vittozzi L
J Biochem Mol Toxicol; 1999; 13(1):53-61. PubMed ID: 9890448
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatic cytochrome P450 isozyme composition in the transgenic rat expressing low level human growth hormone.
Takahashi J; Furuhata Y; Ikeda A; Takahashi M; Iwata H; Kazusaka A; Fujita S
Xenobiotica; 1999 Dec; 29(12):1203-12. PubMed ID: 10647907
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
18. [Effects of ethyl acetate extract of Semen Hoveniae on liver microsomal cytochrome P450 isoenzyme in rat].
Zhang H; Song J; Zhan XA; Tan Y
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1917-21. PubMed ID: 18051907
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte cytochrome P450 expression: inducibility studies in male Wistar rats.
Hannon-Fletcher MP; Barnett YA
Br J Biomed Sci; 2008; 65(1):1-6. PubMed ID: 18476487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
